| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.58B | 1.94B | 1.93B | 1.49B | 2.04B |
| Gross Profit | 143.38M | 213.72M | 180.29M | 35.66M | 234.20M |
| EBITDA | 77.69M | 155.17M | 140.35M | 10.83M | 199.94M |
| Net Income | 39.02M | 92.70M | 77.45M | -31.25M | 98.10M |
Balance Sheet | |||||
| Total Assets | 1.69B | 1.70B | 1.78B | 1.65B | 1.91B |
| Cash, Cash Equivalents and Short-Term Investments | 211.45M | 239.10M | 168.99M | 213.32M | 216.06M |
| Total Debt | 645.66M | 378.42M | 531.21M | 458.62M | 533.68M |
| Total Liabilities | 771.22M | 822.09M | 996.09M | 941.60M | 1.15B |
| Stockholders Equity | 915.00M | 875.06M | 782.28M | 704.57M | 761.22M |
Cash Flow | |||||
| Free Cash Flow | -70.31M | 232.21M | -59.64M | 120.14M | 39.26M |
| Operating Cash Flow | -52.90M | 247.47M | -33.57M | 143.77M | 121.52M |
| Investing Cash Flow | -15.51M | -13.14M | -44.48M | -22.28M | -80.46M |
| Financing Cash Flow | 50.70M | -171.72M | 19.20M | -121.97M | -62.52M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$323.57M | 0.90 | 16.63% | ― | -20.11% | 15.44% | |
63 Neutral | HK$626.24M | 5.45 | 6.04% | 5.81% | 1.35% | -20.70% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | HK$215.22M | 5.37 | 4.40% | ― | -16.71% | -56.57% | |
48 Neutral | HK$1.40B | 16.98 | 1.06% | 2.77% | 1.14% | 26.93% | |
46 Neutral | HK$1.34B | -155.98 | -55.31% | ― | -37.53% | -2640.00% | |
44 Neutral | HK$107.40M | -0.05 | 264.73% | ― | -85.49% | -1298.48% |